医学
阿扎胞苷
骨髓增生异常综合症
内科学
髓系白血病
移植
造血干细胞移植
白血病
肿瘤科
胃肠病学
外科
骨髓
基因表达
化学
DNA甲基化
基因
生物化学
作者
Asmita Mishra,Roni Tamari,Amy E. DeZern,Michael Byrne,Mahasweta Gooptu,Yi‐Bin Chen,H. Joachim Deeg,David A. Sallman,Phillip Gallacher,Anders Wennborg,Denice Hickman,Eyal C. Attar,Hugo F. Fernández
摘要
In patients with mTP53 AML and MDS, post-HCT maintenance therapy with eprenetapopt combined with azacitidine was well tolerated. RFS and OS outcomes were encouraging in this high-risk population.
科研通智能强力驱动
Strongly Powered by AbleSci AI